Serum uric acid level as a marker for mortality and acute kidney injury in patients with acute paraquat intoxication

Nephrology Dialysis Transplantation

Volumn 26, Issue 6, 2011, Pages 1846-1852

  Kim, Jung Hoon ^a   Gil, Hyo Wook ^a   Yang, Jong Oh ^a   Lee, Eun Young ^a   Hong, Sae Yong ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

acute renal failure; paraquat; uric acid

Indexed keywords

PARAQUAT; URIC ACID;

ACUTE DISEASE; ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERURICEMIA; INCIDENCE; INGESTION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARAQUAT POISONING; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEX; URIC ACID BLOOD LEVEL;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; FEMALE; GLOMERULAR FILTRATION RATE; HERBICIDES; HUMANS; MALE; MIDDLE AGED; PARAQUAT; PROGNOSIS; REACTIVE OXYGEN SPECIES; URIC ACID;

EID: 79958130548     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq632     Document Type: Article

References (29)

1. Ames BN, Cathcart R, Schwiers E et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-6862. (Pubitemid 12216861)
2. Padiglia A, Medda R, Longu S et al. Uric acid is a main electron donor to peroxidases in human blood plasma. Med Sci Monit 2002; 8: BR454-BR459. (Pubitemid 35429211)
3. Sautin YY, Nakawawa T, Zharikov S et al. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/ nitrosative stress. Am J Physiol Cell Physiol 2007; 293: C584-C596. (Pubitemid 47235197)
4. Kanellis J, Watanabe S, Li JH et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-1293. (Pubitemid 36706079)
5. Niskanen LK, Laaksonen DE, Nyyssonen K et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men. Arch Intern Med 2004; 164: 1546-1551. (Pubitemid 38970476)
6. Tsouli SG, Liberopoulos EN, Mikhailidis DP et al. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 2006; 55: 1293-1301. (Pubitemid 44354944)
7. Johnson RJ, Kang DH, Feig D et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190. (Pubitemid 36706063)
8. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009; 202: 11-17.
9. Iseki K, Ikemiya Y, Inoue T et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004; 44: 642-650. (Pubitemid 39237608)
10. Vale JR, Meredith TJ, Buckley BM. Paraquat poisoning: clinical features and immediate general management. Hum Toxicol 1987; 6: 41-47. (Pubitemid 17012654)
11. van Vleet TR, Schnellmann RG. Toxic nephropathy: environmental chemicals. Semin Nephrol 2003; 23: 500-508. (Pubitemid 37176695)
12. Hwang KY, Lee EY, Hong SY. Paraquat intoxication in Korea. Arch Environ Health 2002; 57: 162-166.
13. Lee EY, Hwang KY, Yang JO et al. Predictors of survival after acute paraquat poisoning. Toxicol Ind Health 2002; 18: 201-206.
14. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 2004; 8: R204-R212.
15. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
16. Bismuth C, Garnier R, Dally S et al. Prognosis and treatment of paraquat poisoning: a review of 28 cases. J Toxicol Clin Toxicol 1982; 19: 461-474. (Pubitemid 13184937)
17. Proudfoot AT, Prescott LF, Jarvie DR. Haemodialysis for paraquat poisoning. Hum Toxicol 1987; 6: 69-74. (Pubitemid 17012658)
18. Lorenzen JM, Schonenberger E, Hafer C et al. Failed rescue therapy with rapamycin after paraquat intoxication. Clin Toxicol (Phila) 2010; 48: 84-86.
19. Barrueto F, Lee C, Pajoumand M et al. Use of sirolimus in a case of severe paraquat poisoning. Clin Toxicol (Phila) 2008; 46: 778-779.
20. Yang JO, Gil HW, Kang MS et al. Serum total antioxidant statuses of survivors and nonsurvivors after acute paraquat poisoning. Clin Toxicol (Phila) 2009; 47: 226-229.
21. Roncal CA, Mu W, Croker B et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2007; 292: F116-F122. (Pubitemid 46105250)
22. Ejaz AA, Mu W, Kang DH et al. Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2007; 2: 16-21.
23. Varizi ND, Ness RL, Fairshter RD et al. Nephrotoxicity of paraquat in man. Arch Intern Med 1979; 139: 172-174. (Pubitemid 10132265)
24. Gil HW, Yang JO, Lee EY et al. Paraquat induced Fanconi syndrome. Nephrology (Carlton) 2005; 10: 430-432.
25. Kim SJ, Gil HW, Yang JO et al. The clinical features of acute kidney injury in patients with acute paraquat intoxication. Nephrol Dial Transplant 2009; 24: 1232-1237.
26. Johnson RJ, Rideout BA. Uric acid and diet-insights into the epidemic of cardiovascular disease. N Engl J Med 2004; 350: 1071-1073. (Pubitemid 38298984)
27. Siu YP, Leung KT, Tong MK et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47: 51-59. (Pubitemid 41828266)
28. Vaziri ND, Freel RW, Hatch M. Effect of chronic experimental renal insuff iciency on urate metabolism. J Am Soc Nephrol 1995; 6: 1313-1317.
29. Hayden MR, Tyagi SC. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab 2004; 1: 10